Evonile Pharma Ltd reports Q2 FY27 revenue down 38% to ₹56.1 crore and operating EBITDA loss of ₹31.8 crore
- Q2 net loss was ₹77.5 crore; H1 FY27 revenue fell 10% to ₹159.9 crore, with operating EBITDA of ₹3.1 crore and net loss of ₹45.3 crore.
- Results included ₹68.3 crore of exceptional items and ₹15.4 crore of one-time expenses.
- The company said the revenue comparison was affected by its transition to a direct business model.